Nantahala Capital Management - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,847,587
+39.8%
4,101,193
-10.0%
0.18%
+77.2%
Q1 2023$1,321,823
-36.3%
4,558,012
-1.2%
0.10%
-24.6%
Q4 2022$2,074,625
+6.3%
4,611,302
+24.3%
0.13%
+6.3%
Q3 2022$1,952,000
-0.3%
3,710,778
-4.3%
0.13%
+28.6%
Q2 2022$1,958,000
-73.4%
3,877,311
+21.1%
0.10%
-69.9%
Q1 2022$7,361,000
-44.9%
3,200,593
+13.8%
0.33%
-30.6%
Q4 2021$13,364,000
+10.8%
2,813,560
+85.5%
0.47%
+23.7%
Q3 2021$12,060,000
+3.3%
1,516,955
-9.5%
0.38%
+14.5%
Q2 2021$11,672,000
-13.9%
1,677,036
-2.0%
0.33%
-16.2%
Q1 2021$13,560,000
-12.7%
1,712,088
-13.3%
0.40%
-17.7%
Q4 2020$15,538,000
-29.8%
1,974,302
-36.8%
0.48%
-29.0%
Q3 2020$22,145,000
-25.3%
3,123,430
-2.5%
0.68%
-24.3%
Q2 2020$29,645,000
+126.2%
3,204,830
+12.4%
0.89%
+82.1%
Q1 2020$13,106,000
-39.9%
2,852,2600.0%0.49%
-26.8%
Q4 2019$21,791,000
-0.7%
2,852,2600.0%0.67%
-17.5%
Q3 2019$21,934,000
+12.3%
2,852,2600.0%0.81%
+35.0%
Q2 2019$19,538,000
-8.5%
2,852,260
+7.5%
0.60%
-9.6%
Q1 2019$21,351,000
+12.8%
2,652,260
+4.9%
0.67%
+14.4%
Q4 2018$18,929,000
-21.7%
2,527,2600.0%0.58%
-10.6%
Q3 2018$24,186,000
+3.3%
2,527,260
+14.2%
0.65%
-31.3%
Q2 2018$23,414,000
+28.0%
2,213,052
+20.0%
0.95%
+14.9%
Q1 2018$18,299,000
+83.4%
1,844,6730.0%0.82%
+85.8%
Q4 2017$9,980,000
+26.3%
1,844,673
+15.1%
0.44%
+14.7%
Q3 2017$7,902,000
+28.8%
1,602,903
+0.6%
0.39%
-20.5%
Q2 2017$6,133,0001,592,9030.49%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Yu Fan 20,592$347,79824.67%
VR Adviser, LLC 295,034$3,614,1670.38%
IFP Advisors, Inc 2,860$1,7180.00%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders